Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 542,700 shares, an increase of 42.2% from the February 28th total of 381,600 shares. Based on an average daily trading volume, of 720,700 shares, […]